Another Vioxx jury sides with Merck
New Jersey pharmaceutical giant Merck & Co. persuaded a New Orleans federal court jury Wednesday that Vioxx, a painkiller it took off the market two years ago after studies linked it to heart attacks and strokes, did not cause the 2003 heart attack of a Tennessee man who had taken the medicine for six months for arthritis pain.
Click here for more info
Health Roundup: Heart Attack Risk, Meditation, Cold Feet And Colds
A new study finds heart attack patients who took high doses of Cox-2 inhibitors such as Celebrex and Vioxx or non-steroidal anti-inflammatory drugs such as Ibuprofen were at least twice as likely to die compared with people not taking the medications.
Click here for more info
Why the Data Diverge on the Dangers of Vioxx
The results of clinical trials can be open to interpretation and potential corporate pressure, even in leading medical journals.
Read more here
Merck Is Winner in a Vioxx Lawsuit
Merck won a sixth verdict when a federal jury ruled against a Utah man who contended that Vioxx caused his heart attack.
Click here for more info